A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications. The approach, developed at Gladstone Institutes and UC ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 93, No. 21 (Oct. 15, 1996), pp. 11307-11312 (6 pages) Herpes simplex virus vectors are being developed for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback